Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2026-04-02 16:15:11 ET · period of report 2026-03-31 · accession 0001727794-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 16:15 | 2026-03-31 | YARW | Domzalski David | Pres AND CEO, Dir | F - Tax | $0.5975 | -14.2K | 402.0K | -3% | -$8,504 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-31 | F | D | 14,232 | $0.5975 | 401,976 | D | — | — | (F1) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |